37
The Arvia Process: Priority Substances and Pharmaceutical Residues & Disinfection Arvia Technology Ltd Nigel W. Brown

The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

The Arvia Process:

Priority Substances and Pharmaceutical Residues&

Disinfection

Arvia Technology Ltd

Nigel W. Brown

Page 2: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Overview

• Introduction

• Micro-organics Removal

• Disinfection

• Conclusions/On-going Work

• Acknowledgments and Questions

Page 3: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Introduction - Arvia Technology

• Arvia Technology is VC backed SME originating from The University of Manchester

• 22 full time employees based at The Heath Business and Technical Park

• Provides innovative advanced tertiary water and water recycling treatment with its Organics Destruction Cell (ODC)

• Active both in the water and nuclear sectors

• Arvia are focused on deploying pilot plants

• Global IPR in place – 25 patents granted with 33 pending in 9 patent families

Page 4: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

NyexTM – An Adsorbent & Electrode

Adsorption

Energy efficient, trace level, organics destruction with no secondary waste

Electrochemical Oxidation

• Concentrates organics on a surface• Achieves low discharge consents

• Destruction of recalcitrant organics• Chemical free, onsite operation @

room temperature and pressure

Page 5: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Laboratory Scale Sequential Batch Reactor

Page 6: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Continuous Operation

Page 7: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

ODC™ Building Blocks

  ODC 22-100

Flow (Up to) 22,000 L/hrs

Max Inlet COD 2,000 ppm

Typical Operating Current 50 Amps

Expected Operating Voltage 20 - 50 Volts

Foot print 1.2 m x 0.7 m

7

Page 8: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Arvia Technology

• Provides innovative advanced tertiary water and water recycling treatment with

its Organics Destruction Cell (ODC)

• The ODC provides targeted removal of organics to:

ü Safely discharge wastewater to the environment (including disinfection)

ü Enable water to be reused

ü Preferentially remove contaminants of concern

ü Meet regulatory targets for COD and micro-pollutants

• Competitive against AOP processes (UV/TiO2 and Ozone/H2O2) for removing

low and trace organics (change in <100mg/l COD)8

Page 9: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

ODC™ Proposition

The ODC™ reduces the common measure of water pollution, known as Chemical Oxygen Demand, as well as removing colour and persistent organic micro-pollutants.

ü Micro-pollutant removal for water utilities96% removal of micro-pollutants at 0.1 kWh/m3

ü Industrial wastewater polishing for effluent re-use or safe dischargeRemove recalcitrant COD to <10 ppm at 18 kWh/kg COD

ü Color removal from water and wastewaterTreat dyes, inks and other sources of color

Page 10: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Colour removal/Organics Polishing

Page 11: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

ODC™ Benefits

ü Chemical free and environmentally sound

ü No toxic by-products and no sludge

ü Modular and scalable design

ü Safe to operate system and low maintenance

ü Energy used proportional to the organics destroyed. The lower the concentration of organics the more cost-effective!

11

Page 12: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Case Studies

Page 13: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Micro-pollutants in Wastewater

12

At its pilot plant with a major British water utility company Arvia’s ODC is delivering previously

unachievable results in removing micro-pollutants.

Treatment parameters:

Optimised energy consumption: 0.1 - 0.3 kWh/mᵌ Treatment target: parts per billion level

80% removal of oestrogens, Ibuprofen, Carbamazepine, Diclofenac, Fluoxetine

Page 14: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Large scale treatment of water spiked

with a wide range of micro-pollutantsPharmaceutical residues including antibiotics, prescription drugs and non prescription drugs

treated using the Arvia process showed on average >90% removal

Power (KWh) is for the treatment of cocktail of compounds present in the waste

and not for individual compounds

Page 15: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Removal of non-prescription drugs and steroids

• >90% removal of Ibuprofen and Diclofenac

Page 16: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Removal of steroids

• >80% removal of EE2.

• Concentration of analyte in ng/l, and deviation in result is within error of measurement.

Page 17: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

The ‘Metaldehyde Problem’

• Molluscicide-selective pesticide applied to control snails and slugs

– 2008-2012, >1400 tonnes of metaldehyde has been used (FERA,

2013)

• Long-lived in the environment

• Soluble in water (200 mg/L at 20oC)

– Leaching of metaldehyde in water sources is a serious threat to water

quality (fwi, 2014)

• 200+ plants fail EU standards in UK

17

Page 18: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Metaldehyde trial result

18

• The Arvia process could take water

from out of to into specification

(0.1 ppb)

• Discharge consent achieved for every

single pass

• 96% removal of metaldehyde from

water

• Treatment cost was shown to be

0.5 kWhrs/m3

Page 19: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Summary

• The technology delivers hard (recalcitrant) COD removal,

colour and organic micro-pollutant removal

• The Arvia ODC combines the advantages of adsorption

and advanced oxidation within a single unit

• There is no by-product formation, no secondary waste

generated and no chemicals used in the process which

differentiates the technology from other tertiary treatment

technologies

Page 20: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Disinfection

Page 21: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Antibiotic Resistance

All 193 UN member states have agreed to combat the

proliferation of drug-resistant infections, estimated to kill

more than 700,000 people each year (The Guardian

21/9/16)

UN secretary general, Ban Ki-moon, said antimicrobial

resistance is a “fundamental threat” to global health and

safety at the first general assembly meeting on drug-

resistant bacteria. (The Guardian 21/9/16)

To fight the growing problem of infections that can't be

treated, the administration of President Barack Obama is

implementing a five-year national action plan at a cost of

$1.2 billion.

Drug-resistant bacteria, viruses and parasites are driving

a global health crisis. It threatens not only our ability to

treat deadly infections, but almost every aspect of

modern medicine: from cancer treatment to Caesarean

sections, therapies that save thousands of lives every

day rely on antibiotics that could soon be lost. We are

failing to contain the rise of resistance, and failing to

develop new drugs to replace those that no longer work.

We are heading for a post-antibiotic age. Dr Jeremy

Farrar, Director of the Wellcome Trust

The soaring number of antibiotic-resistant infections

poses such a great threat to society that in 20 years’ time

we could be taken back to a 19th century environment

where everyday infections kill us as a result of routine

operations. Professor Dame Sally Davies, Chief Medical

Officer for England

Page 22: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Hospital wastewaters

Hospital wastewaters contain as much as 100 times as much antibiotic levels

than Sewage Treatment Plants. Galvin et al have shown that hospital

wastewaters have a higher proportion of antibiotic resistant E Coli than

wastewaters upstream of the hospital. STW failed to remove a number of

antibiotic resistant strains. (Katouli et al, Science Forum and Stakeholder

Engagement: Building Linkages, Collaboration and Science Quality , 225 – 229)

After administration antibiotic substances are released into the effluent via

patient excreta. These drugs can pass through sewage works can enter the

aquatic environment and eventually reach drinking water. (Kummerer &

Henninger, Clinical microbiology and infection, 2003, Vol 9, 1203-1214)

“Municipal sewage treatment plants are not designed to deal with medicinal

and biological waste. This is why we can detect these substances in our

waterways. Ulf Nielson Chief Environmental planner (Consulting firm DHI

Denmark). “Even in very low concentrations, the substances in hospital

wastewater can affect animal life. Estrogens, for example, can cause

hermaphroditic fish, while pain killers are poisonous to trout and certain

psychopharmaceuticals can affect fish and bird behaviour.” (The Guardian

12/11/14)

Hospital wastewaters contain a variety of toxic and persistent substances

such as pharmaceuticals, radio nuclides, solvents and disinfectants for

medical purposes. Many of these compounds belong to the so called

emerging contaminants, which may be candidates for future regulation.

(Verlicchi et al, Journal of Hydrology 389 (2010) 416–428)

Page 23: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Adsorption 1

E. Coli Initial conc. 1.6 * 109 CFU ml-1 Nyex Dose rate 100 g/lAverage of 5 trials Limit of detection 20 CFU ml-1

8.5 Log reduction after 20 mins

Page 24: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Adsorption 1

Hussain et al, 2014, Water Research 54, 170-178

Page 25: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Electrochemical Regeneration

E. Coli Initial conc. 2.5 * 108 CFU ml-1 Fresh batch used each cycleAverage of 5 trials Limit of detection 20 CFU ml-1Operating conditions Current density 10 mA-2 for 20 mins

Page 26: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Micro-organisms

• Bacteria

• Pseudomonas aeruginosa

• Staphylococcus aureus

• Legionealla pneumophilia

• Fungi

• Aspergillus awamori

• Yeast

• Saccharomyces cerevisiae

• Rhodosporidium turoloides

Hussain et al, J. Ind Eng Chem. 2016 In press

S. Cerevisiae

Page 27: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Hussain et al, J. Ind Eng Chem. 2016 In press

L. pneumophila stained with safranin

Page 28: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Algae cells Adsorption

Scanning Electron Micrographs of microalgae cells on the adsorbent

Page 29: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Algae Regeneration

Scanning Electron Micrographs of microalgae cells on the adsorbent

• Dimple appearing on the side of the microalgae cells that is in contact with the adsorbent.

• Possibly due to electrochemical regeneration of adsorbent

Page 30: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Algae Regeneration

Scanning Electron Micrographs of microalgae cells following regeneration

• An opening can be observed from what looks like a ruptured Microalgae cell as a result of electrochemical regeneration

• Release of intracellular material from micro-algae.

• Possibly due to wall rupture as a result of electrochemical regeneration of the adsorbent

Page 31: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Disinfection Mechanisms

• Direct Electrochemical disinfection

• Electro-chlorination

• pH

Page 32: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Continuous treatment system

0 A

10 A

5 A

Page 33: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

ODC™ Benefits

ü Chemical free

ü No toxic by-products

ü No waste sludge

ü Residual Chlorination

ü Modular and scalable design (suitable for small scale operation)

ü Safe to operate system and low maintenance

ü Energy used proportional to the organics destroyed. The lower the concentration of organics the more cost-effective!

Page 34: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Acknowledgements

Prof E.P.L. Roberts University of Calgary

Dr. S. N. Hussain Punjab University

Dr Akinlabi Adeyem University of Manchester

Prof J. Lloyd, Prof A. McBain, Dr R. Kimber, University of Manchester

Dr C. Halsall, S. O’Rouke3 University of Lancaster

Team at Arvia Technology

Page 35: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Wastewater as resource

“Globally billions of Euros are spent treating trillions of litres of

wastewater every year, consuming substantial amounts of energy

However, this wastewater could act as a renewable resource,

saving significant quantities of energy and money, as it contains

organic pollutants which can be used to produce electricity”

European Commission (2013) Bio-electrochemical Systems, wastewater

treatment, bioenergy and valuable chemicals delivered by bacteria.

Future Brief.

Page 36: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Microbial Fuel Cell Research BC Environmental

0 2 4 6 8 10 12

Cell Voltage (mV) against Time (h)

Time (h)

Page 37: The Arvia Process: Priority Substances and Pharmaceutical ... N (2016) The Arvia... · Introduction - Arvia Technology • Arvia Technology is VC backed SME originating from The University

Thank You

www.arviatechnology.com

E-mail: [email protected]

Tel: +44 (0) 1928 515 315